High resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood acute myeloid leukemia

High resolution melting curve analysis, a rapid and affordable method for mutation analysis in childhood acute myeloid leukemia

Background: Molecular genetic alterations with prognostic significance have been described in childhood acute myeloid leukemia (AML). The aim of this study was to establish cost-effective techniques to detect mutations of FMS-like tyrosine kinase 3 (FLT3), Nucleophosmin 1 (NPM1), and a partial tande...

Full description

Bibliographic Details
Main Authors:	Yin eLiu, Jingyan eTang, Peter eWakamatsu, Huiliang eXue, Jing eChen, Paul S Gaynon, Shuhong eShen, Weili eSun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-09-01
Series:	Frontiers in Pediatrics
Subjects:	Acute Myeloid Leukemia childhood FLT3 NPM1 MLL High Resolution Melting curve analysis
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fped.2014.00096/full

Similar Items

The biology and targeting of FLT3 in pediatric leukemia
by: Colleen eAnnesley, et al.
Published: (2014-09-01)

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype
by: Irina Stepanovna Martynkevich, et al.
Published: (2010-12-01)

Acute Myeloid Leukaemia with Gene Mutation: A Correlation with Haematological and Immunophenotypic Characteristics and Our Experience in a Tertiary Care Cancer Center in South India
by: Rachna KHERA, et al.
Published: (2018-05-01)

Cytogenetics and FLT3-ITD mutation predict clinical outcomes in non transplant patients with acute myeloid leukemia
by: Pimjai Niparuck, et al.
Published: (2019-01-01)

Estudo de alterações moleculares e sua relação com dados clínico-laboratoriais em pacientes adultos com leucemia mieloide aguda
by: LIMA, Aleide Santos de Melo
Published: (2015)

Molecular Genetic Markers in Acute Myeloid Leukemia
by: Sophia Yohe
Published: (2015-03-01)

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
by: Serena Salehzadeh, et al.
Published: (2019-04-01)

NPM1 and FLT3-(ITD) Gene mutations and laboratory findings in patients with acute myeloid leukemia in Northwest of Iran
by: Sanaat Z, et al.
Published: (2014-10-01)

The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia
by: Biao Wang, et al.
Published: (2021-07-01)

Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study
by: Tripon Florin, et al.
Published: (2019-07-01)

Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
by: Jean F. Kloppers, et al.
Published: (2021-06-01)

Clinical implications of recurrent gene mutations in acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-03-01)

Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis 
by: Huang Y, et al.
Published: (2019-05-01)

Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
by: Mona Salah, et al.
Published: (2021-06-01)

A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology
by: Hala Skayneh, et al.
Published: (2019-08-01)

Mutación NPM1-A en pacientes cubanos con leucemia mieloide aguda, su coexistencia con otras alteraciones moleculares
by: Ana María Amor-Vigil, et al.

Bone Marrow Clonogenic Myeloid Progenitors from <i>NPM1</i>-Mutated AML Patients Do Not Harbor the <i>NPM1</i> Mutation: Implication for the Cell-Of-Origin of <i>NPM1+</i> AML
by: Rafael Diaz de la Guardia, et al.
Published: (2020-01-01)

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
by: Faraoni Isabella, et al.
Published: (2012-06-01)

FLT3 Mutations in Acute Myeloid Leukemia: Key Concepts and Emerging Controversies
by: Vanessa E. Kennedy, et al.
Published: (2020-12-01)

Genomic characterization of mixed lineage leukemias
by: S. Dogan
Published: (2020-03-01)

CDK6 Inhibition: A Novel Approach in AML Management
by: Iris Z. Uras, et al.
Published: (2020-04-01)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
by: Shano Naseem, et al.
Published: (2021-01-01)

CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells
by: Vincenzo Maria Perriello, et al.
Published: (2021-01-01)

SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE
by: Nishit Gupta, et al.
Published: (2019-02-01)

Acute myeloid leukemia and transcription factors: role of erythroid Krüppel-like factor (EKLF)
by: Ayala Rosa, et al.
Published: (2012-06-01)

Prognostic Value of Genetic Mutations in Patients with Acute Myeloid Leukemias: Results of a Cooperative Study of Hematology Clinics of Saint Petersburg (Russia) and Charite Clinic (Germany)
by: EV Motyko, et al.
Published: (2019-03-01)

TXNIP induces growth arrest and enhances ABT263‐induced apoptosis in mixed‐lineage leukemia‐rearranged acute myeloid leukemia cells
by: Mina Noura, et al.
Published: (2020-08-01)

Rewiring the Epigenetic Networks in MLL-Rearranged Leukemias: Epigenetic Dysregulation and Pharmacological Interventions
by: Anthony K. N. Chan, et al.
Published: (2019-05-01)

Non-canonical H3K79me2-dependent pathways promote the survival of MLL-rearranged leukemia
by: William F Richter, et al.
Published: (2021-07-01)

Acquisition of mixed lineage leukemia rearrangement in a chronic myeloid leukemia patient while on imatinib
by: Adriana Zámečníkova
Published: (2011-08-01)

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant <i>NPM1</i> and <i>FLT3</i> Mutations
by: Barbora Brodská, et al.
Published: (2019-06-01)

Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
by: Anna Wojtuszkiewicz, et al.
Published: (2021-08-01)

Gilteritinib: a novel FLT3 inhibitor for acute myeloid leukemia
by: Juanjuan Zhao, et al.
Published: (2019-09-01)

Dysregulation of CCAAT/enhancer binding protein-alpha (CEBPA) expression in the bone marrow of acute myeloid leukemia patients
by: Naglaa M. Hassan, et al.
Published: (2021-04-01)

Mutations within the Activation Loop Domain of FLT3 in Two Pediatric Patients with Refractory Infant Acute Myeloid Leukemia
by: Nicole Muhlbauer, et al.
Published: (2020-03-01)

Modelling the Effects of MCM7 Variants, Somatic Mutations, and Clinical Features on Acute Myeloid Leukemia Susceptibility and Prognosis
by: Florin Tripon, et al.
Published: (2020-01-01)

First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical FLT3 Mutations
by: Naval Daver, et al.
Published: (2020-08-01)

Molecular Diagnosis of FLT3 Mutations in Acute Myeloid Leukemia Patients
by: EK Zaikova, et al.
Published: (2019-03-01)

FLT3 Gene Mutation in Acute Myeloid Leukemia: Correlation with Hematological, Immunophenotypic, and Cytogenetic Characteristics
by: Sunitha Shankaralingappa, et al.
Published: (2021-06-01)

Significance of NPM1 Gene Mutations in AML
by: Andrew Hindley, et al.
Published: (2021-09-01)

Cannot write session to /tmp/vufind_sessions/sess_kceqkm9n3l6c5o9dca20a65vqg